FEATURES

New Results on Essilor Stellest Myopia Control Lens to be Presented at ARVO 2021 Meeting

CHARENTON-LE-PONT, France—Essilor will unveil the two-year clinical trial results of Stellest, its proprietary spectacle lens that is designed to control myopia. The two-year results demonstrate that Essilor Stellest lenses slow down myopia progression by 67 percent on average.  Read more...


Private Equity Event Scheduled for Vision Expo East

NEW YORK—“Demystifying Private Equity and Its Role in Optometry” is returning to Vision Expo East, to be held June 2-5 in Orlando, Fla. The 90-minute program, developed by Review of Optometric Business for Vision Expo, provides an overview of PE investment strategies and opportunities for OD-owners.  Read more...


Lensabl Launches All-Online Vision Benefit Plans

LOS ANGELES—Lensabl, the direct-to-consumer eyeglass lens replacement and contact lens provider, is adding a vision benefit platform, Lensabl+, to its online offerings.  Read more...


MOST READ STORIES

CURRENT
ISSUE

March 2021

  • Table of Contents
  • Cover Story
  • Issue Archives
March 2021